Physician profile
Hung J Vu
NPI 1548234610
$4,058.68
in general payments reported to CMS, 2019-2025
22 companies · $83.36 in 2025
The $83.36 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $95.83 · 2021: $1,887 · 2022: $1,062 · 2023: $508 · 2024: $232 · 2025: $83.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,884.58 | 2019-2022 | |
| Smith+Nephew, INC. | $789.56 | 2021-2025 | Hat-Trick, Healicoil, Twinfix / Durabraid |
| Collegium Pharmaceutical, INC. | $239.34 | 2019-2023 | Xtampza |
| Abbott Laboratories | $146.62 | 2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.13 | 2021-2023 | Relistor |
| Nevro Corp. | $114.19 | 2021 | |
| Stimwave Technologies Incorporated | $111.00 | 2022 | |
| Abbvie INC. | $99.71 | 2021-2023 | Qulipta, Ubrelvy |
| Almatica Pharma LLC | $97.58 | 2021 | |
| Grt US Holding, INC. | $90.00 | 2021-2022 | |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Baudax Bio INC. | $50.07 | 2021 | |
| Tersera Therapeutics LLC | $41.97 | 2019 | |
| Amgen INC. | $34.33 | 2019-2020 | |
| Pfizer INC. | $29.36 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $27.33 | 2019 | |
| Medtronic, INC. | $24.76 | 2022 | |
| Biodelivery Sciences International, INC. | $22.71 | 2020 | |
| Forte Bio-Pharma LLC | $14.21 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.92 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.57 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hung Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.